Is there a role for Desmopressin as an alternative to platelet transfusion prior to procedures or Radiological InterVEntions in thrombocytopenic critically ill patients (DRIVE)? Results of a randomised double-blind placebo-controlled feasibility trial
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Wiley
2022
|